140 related articles for article (PubMed ID: 31095781)
61. Isoquercitrin inhibits bladder cancer progression in vivo and in vitro by regulating the PI3K/Akt and PKC signaling pathways.
Chen F; Chen X; Yang D; Che X; Wang J; Li X; Zhang Z; Wang Q; Zheng W; Wang L; Wang X; Song X
Oncol Rep; 2016 Jul; 36(1):165-72. PubMed ID: 27177091
[TBL] [Abstract][Full Text] [Related]
62. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway.
Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y
J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499
[TBL] [Abstract][Full Text] [Related]
63. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
[TBL] [Abstract][Full Text] [Related]
64. PIN1 in hepatocellular carcinoma is associated with TP53 gene status.
Bae JS; Noh SJ; Kim KM; Jang KY; Park HS; Chung MJ; Park BH; Moon WS
Oncol Rep; 2016 Oct; 36(4):2405-11. PubMed ID: 27499097
[TBL] [Abstract][Full Text] [Related]
65. The Effect of Resveratrol on Cell Viability in the Burkitt's Lymphoma Cell Line Ramos.
Jara P; Spies J; Cárcamo C; Arancibia Y; Vargas G; Martin C; Salas M; Otth C; Zambrano A
Molecules; 2017 Dec; 23(1):. PubMed ID: 29267250
[TBL] [Abstract][Full Text] [Related]
66. Effect of HPV E6/E7 siRNA with Chemotherapeutic Agents on the Regulation of TP53/E2F Dynamic Behavior for Cell Fate Decisions.
Rajasekaran N; Jung HS; Bae SH; Chelakkot C; Hong S; Choi JS; Yim DS; Oh YK; Choi YL; Shin YK
Neoplasia; 2017 Oct; 19(10):735-749. PubMed ID: 28843398
[TBL] [Abstract][Full Text] [Related]
67. Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis.
Yang S; Ma J; Xiao J; Lv X; Li X; Yang H; Liu Y; Feng S; Zhang Y
Anat Rec (Hoboken); 2012 Aug; 295(8):1260-6. PubMed ID: 22619087
[TBL] [Abstract][Full Text] [Related]
68. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2.
Park BH; Lim JE; Jeon HG; Seo SI; Lee HM; Choi HY; Jeon SS; Jeong BC
Oncotarget; 2016 Sep; 7(39):63870-63886. PubMed ID: 27564099
[TBL] [Abstract][Full Text] [Related]
69. Novel quinazoline HMJ-30 induces U-2 OS human osteogenic sarcoma cell apoptosis through induction of oxidative stress and up-regulation of ATM/p53 signaling pathway.
Chiu YJ; Hour MJ; Lu CC; Chung JG; Kuo SC; Huang WW; Chen HJ; Jin YA; Yang JS
J Orthop Res; 2011 Sep; 29(9):1448-56. PubMed ID: 21425328
[TBL] [Abstract][Full Text] [Related]
70. Combined metformin and resveratrol confers protection against UVC-induced DNA damage in A549 lung cancer cells via modulation of cell cycle checkpoints and DNA repair.
Lee YS; Doonan BB; Wu JM; Hsieh TC
Oncol Rep; 2016 Jun; 35(6):3735-41. PubMed ID: 27109601
[TBL] [Abstract][Full Text] [Related]
71. Resveratrol inhibits cell cycle progression by targeting Aurora kinase A and Polo-like kinase 1 in breast cancer cells.
Medina-Aguilar R; Marchat LA; Arechaga Ocampo E; Gariglio P; García Mena J; Villegas Sepúlveda N; Martínez Castillo M; López-Camarillo C
Oncol Rep; 2016 Jun; 35(6):3696-704. PubMed ID: 27109433
[TBL] [Abstract][Full Text] [Related]
72. Galangin Induces p53-independent S-phase Arrest and Apoptosis in Human Nasopharyngeal Carcinoma Cells Through Inhibiting PI3K-AKT Signaling Pathway.
Lee CC; Lin ML; Meng M; Chen SS
Anticancer Res; 2018 Mar; 38(3):1377-1389. PubMed ID: 29491062
[TBL] [Abstract][Full Text] [Related]
73. Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway.
Mohapatra P; Satapathy SR; Das D; Siddharth S; Choudhuri T; Kundu CN
Toxicol Appl Pharmacol; 2014 Mar; 275(3):221-31. PubMed ID: 24467951
[TBL] [Abstract][Full Text] [Related]
74. L-securinine induces apoptosis in the human promyelocytic leukemia cell line HL-60 and influences the expression of genes involved in the PI3K/AKT/mTOR signaling pathway.
Han S; Zhang G; Li M; Chen D; Wang Y; Ye W; Ji Z
Oncol Rep; 2014 May; 31(5):2245-51. PubMed ID: 24676995
[TBL] [Abstract][Full Text] [Related]
75. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis.
McCubrey JA; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Rakus D; Gizak A; Libra M; Cervello M; Montalto G; Yang LV; Abrams SL; Steelman LS
Adv Biol Regul; 2017 Jan; 63():32-48. PubMed ID: 27776972
[TBL] [Abstract][Full Text] [Related]
76. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
[TBL] [Abstract][Full Text] [Related]
77. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
[TBL] [Abstract][Full Text] [Related]
78. Combination of Resveratrol and Quercetin Causes Cell Growth Inhibition, DNA Damage, Cell Cycle Arrest, and Apoptosis in Oral Cancer Cells.
Singh V; Singh R; Kujur PK; Singh RP
Assay Drug Dev Technol; 2020 Jul; 18(5):226-238. PubMed ID: 32423320
[No Abstract] [Full Text] [Related]
79. Additive effects of resveratrol and doxorubicin on bladder cancer cells.
Soares LBM; Lima APB; Melo AS; Almeida TC; de Medeiros Teixeira LF; da Silva GN
Anticancer Drugs; 2022 Jan; 33(1):e389-e397. PubMed ID: 34486536
[TBL] [Abstract][Full Text] [Related]
80. Synthesis, characterization and antiproliferative effects of naphtho [2,3-
Ferreira GM; Lima APB; Pereira GR; Silva GND; Brandão GC
Nat Prod Res; 2023 Jul; 37(13):2285-2292. PubMed ID: 35133203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]